• $1,627.00
    Market Cap
  • 100.00%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0002
$0.0002
$0.0002
1-Year Range
$0.0001
$0.0002
$0.0002
Latest Close$0.0002
Change
$0.00 (0.00%)
Volume375
Market Cap$1,627.00
Shares Outstanding8.1M
P/E (TTM)-0.20
Diluted EPS (TTM)-$0.001
Enterprise Value-$428,197.00

Information as of 02/17/2026

Company Profile

$1,627.00
Market Cap
-$8,999.00
Net Income
Sector: Healthcare
Industry: Biotechnology
150 Isabella Street, Ottawa, ON, Canada, K1S 1V7
613 727 1397

ZIM Corporation operates in the biomedical and emerging technology companies. It focuses on developing intellectual property, and research and development in the areas of new synthetic drugs and Immunotherapies. The company also offers spherical metal powders for additive manufacturing; and develops novel biomaterial for regenerative medicine. ZIM Corporation was founded in 1997 and is headquartered in Ottawa, Canada.

Key Executives

  • John A. Chapman
  • Michael C. J. Cowpland

Current Ownership Distribution

  • Other5.6M (68.98%)
  • Insiders2.5M (31.02%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)